INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9%
Mon, 27 Jan

INDOCO REMEDIES has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

INDOCO REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m2,6262,9202,893-0.9%10.2%
Other incomeRs m66724.1%26.3%
TurnoverRs m2,6312,9262,901-0.9%10.2%
ExpensesRs m2,3782,5982,542-2.2%6.9%
Gross profitRs m2483213519.2%41.7%
DepreciationRs m177180176-2.5%-0.8%
InterestRs m37546929.1%86.3%
Profit before taxRs m399311321.6%190.3%
TaxRs m-1420200.0%
Profit after taxRs m53739327.4%74.9%
Gross profit margin%9.411.012.1
Effective tax rate%-36.921.317.5
Net profit margin%2.02.53.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 10.2% on a year-on-year (YoY) basis. The expenses were up by 6.9% YoY during the same period.
  • The company's operating profit increased by 41.7% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 12.1% in 3QFY20 as against 9.4% in 3QFY19.
  • Depreciation charges declined by 0.8% and finance costs increased by 86.3% YoY, respectively.
  • Other income increased by 26.3% YoY during the quarter.
  • Net profit for the quarter increased by 74.9% YoY. Net profit margins during the quarter increased from 2.0% in 3QFY19 to 3.2% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.9% on a quarter-on-quarter (QoQ) basis. The expenses were down by 2.2% QoQ during the same period.
  • The company's operating profit increased by 9.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 12.1% in 3QFY20 as against 11.0% in 2QFY19.
  • Net profit for the quarter increased by 27.4% QoQ, while net profit margins increased from 2.5% in 2QFY19 to 3.2% in 3QFY20.

To see how INDOCO REMEDIES has performed over the last eight quarters,please visit here.

Watch the Replay: The Smallcap Revival Summits

INDOCO REMEDIES Share Price Performance

Over the last one year,INDOCO REMEDIES share price has moved up from Rs 182.0 to Rs 225.0, registering a Gain of Rs 43.0 or around 23.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,318.8 (up 1.5%). Over the last one year it has moved up from 13,948.3 to 14,318.8, a gain of 371 points (up 2.7%).

Overall, the S&P BSE SENSEX is up 14.2% over the year.

Current Valuations

At the current price of Rs 225.0, the price to earnings (P/E) ratio of INDOCO REMEDIES stands at 68.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.1 times.

Equitymaster requests your view! Post a comment on "INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9%". Click here!

  

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Jan 28, 2021 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS